Onkologie, Hämatologie - Daten und Informationen
SitemapSitemap  


Literatur zu Kapitel 4.3: Strahlentherapie von Melanomen

Autor/en: M. Stuschke
Letzte Änderung: 01.12.2006
  • Ang KK et al.
    Postoperative radiotherapy for cutaneous melanoma of the head and neck region.
    Int J Radiat Oncol Biol Phys 1994;30:795-798.


  • Anrews DW et al.
    Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
    Lancet 2004;363:1665-1672.


  • Ballo MT et al.
    Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.
    J Clin Oncol 2002a;20:4555-4558.


  • Ballo MT et al.
    Adjuvant irradiation for axillary metastases from malignant melanoma.
    Int J Radiat Oncol Biol Phys 2002b;52:964-972.


  • Burmeister BH et al.
    Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity.
    ANZ J Surg 2002;72:344-348.


  • Collaborative Ocular Melanoma Study Group.
    The Collaborative Ocular Melanoma Study (COMS) randomised trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS Report No. 10.
    Am J Ophthalmol 1998;125:779-796.


  • Corry J et al.
    Nodal radiation therapy for metastatic melanoma.
    Int J Radiat Oncol Biol Phys 1999;44:1065-1069.


  • Courdi A et al.
    Results of proton therapy of uveal melanomas treated in Nice.
    Int J Radiat Oncol Biol Phys 1999;45:5-11.


  • Creagan E, Cupps R, Ivins J.
    Adjuvant radiation therapy for regional nodal metastases from malignant melanoma.
    Cancer 1978;42:2206-2210.


  • Diener-West M et al, for the Collaborative Ocular Melanoma Study Group.
    The COMS randomized trial of iodine 125 brachytherapy for choroideal melanoma, III: initial mortality findings. COMS Report No. 18.
    Arch Ophthalmol 2001;119:969-982.


  • Egger E et al.
    Eye retention after proton beam radiotherapy for uveal melanoma.
    Int J Radiat Oncol Biol Phys 2003;55:867-880.


  • Ellerhorst J et al.
    Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases.
    Int J Radiat Oncol Biol Phys 2001;49:93-97.


  • Fife K, Thompson JF.
    Lymph-node metastases in patients with melanoma: what is the optimum management?
    Lancet Oncol. 2001;2:614-621.


  • Fuss M et al.
    Proton radiation therapy for medium and large choroideal melanoma: preservation of the eye and its functionality.
    Int J Radiat Oncol Biol Phys 2001;49:1053-1059.


  • Gragoudas E et al.
    Evidence-based estimated of outcome in patients irradiated for intraocular melanoma.
    Arch Opthalmol 2002;120:1665-1671.


  • Gragoudas E et al.
    A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma.
    Arch Opthalmol 2000;118:773-778.


  • Höcht S et al.
    Proton therapy of uveal melanomas in Berlin.
    Strahlenther Onkol 2004;180:419-424.


  • Kirkwood J, Strawderman M, Ernstoff M.
    Interferon alpha-2b adjuvant therapy of high risk resected cutaneus melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
    J Clin Oncol 1996;14:1036-1044.


  • Lee RJ et al.
    Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Int J Radiat Oncol Biol Phys 2000;46:467-474.


  • Margolin K et al.
    Temozolomide and whole brain irradiation in melanoma metastaic to the brain: a phase II of the Cytolin Working Group.
    J Cancer Res Clin Oncol 2002;128:214-218.


  • Mizoe J et al.
    Dose escalation study of carbon ion radiotherapy for locally advanced head and neck cancer.
    Int J Radiat Oncol Biol Phys 2004;60:358-354.


  • Mori Y, Kondziolka D, Flickinger JC.
    Stereotactic radiosurgery for cerebral metastatic melanoma. Factors affecting local control and survival.
    Int J Radiat Oncol Biol Phys 1998;42:581-589.


  • Morris SL et al.
    A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma.
    Br J Cancer 2004;91:829-833.


  • Nag S et al, for the American Brachytherapy Society.
    The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
    Int J Radiat Oncol Biol Phys 2003;56:544-555.
    National Cancer Institute Physician Data Query.
    http://www.nci.nih.gov/cancerinfo


  • Overgaard J et al.
    Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.
    Lancet 1995;345:540-543.


  • Rate WR, Solin LJ, Turrisi AT.
    Palliative radiotherapy for metastatic malignant melanoma: Brain metastases, bone metastases and spinal cord compression.
    Int J Radiat Oncol Biol Phys 1988;15:859-864.


  • Reid GC, Schmidt RW, Roberts JA.
    Primary melanoma of the vagina: a clinicopathologic analysis.
    Obstet Gynecol 1989;74:190.


  • Sause WT et al.
    Fraction size in external beam radiation therapy in the treatment of melanoma.
    Int. J. Radiat Oncol Biol Phys 1991;20:429-432.


  • Selek U et al.
    Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Int J Radiat Oncol Biol Phys 2004;59:1097-1106.


  • Shibuya H et al.
    The efficacy of radiation therapy for malignant melanoma in the mucosa of the upper jaw: an analytic study.
    Int J Radiat Oncol Biol Phys 1992;25:35-39.


  • Trott KR.
    The optimal radiation dose per fraction for the treatment of malignant melanomas.
    Int J Radiat Oncol Biol Phys 1991;20:905-907.


  • Van Nostrand KM, Lucci JA, Schell M.
    Primary vaginal melanoma: improved survival with radical pelvic surgery.
    Gynecol Oncol 1994;55:234.


  • Wada H, Nemoto K, Ogawa Y.
    A multi institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in northern Japan.
    Int J Radiat Oncol Biol Phys 2004;59:495-500.


  • Yu G et al.
    Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery.
    Int J Radiat Oncol Biol Phys 2002;52:1277-1287.


Bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag"; Publikation als Buch: Deutscher Ärzte-Verlag  Deutscher Ärzte-Verlag
[Mehr]
Aktuelle Berichte vom 54th
ASH Annual Meeting 2012,
Atlanta, Georgia, USA [Mehr]
2012 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch:
mehr 
[Mehr]